Inito's $29M Series B puts Bertelsmann India Investments in the lead

Inito has raised $29M in a Series B round led by Bertelsmann India Investments, according to StartupTalky's running Indian startup funding tracker, where the deal appears in the table covering December 9 to December 15, 2025.

The company builds at-home hormone tracking products for fertility monitoring. In the tracker's sector taxonomy it sits under Retail > Mom & Baby Care, and its headquarters are listed as Karnataka, placing it in one of the country's densest clusters for consumer health and diagnostics startups.

The entry confirms three things: the $29M figure, the Series B label, and Bertelsmann India Investments as lead. The tracker does not disclose a valuation, revenue, headcount, or the company's plans for the capital.

The round is one of the larger consumer-facing cheques recorded in that mid-December window, a week that StartupTalky's table shows was otherwise dominated by financial services and enterprise software. Alongside Inito, the December 9–15 slate included Fibe's $35M Series F led by IFC, BlackSoil's $7.2M Series C led by FMO, Skydo's $10M Series A led by SIG Venture Capital, and Smart Joules' $10M Series B led by SBI Ventures. The single biggest line in the same table is Swiggy's $1.2B post-IPO round led by Nippon — a reminder that the period's headline totals were skewed by late-stage and listed-company capital rather than venture rounds.

For Inito, the Series B marks a step up in round size and investor profile relative to seed-stage peers tracked the same month, and Bertelsmann India Investments' involvement gives the company a backer with an existing portfolio in Indian consumer and education businesses.

StartupTalky's tracker is updated weekly and also lists a second December table covering December 16–29, which Inito does not appear in.